Health IT Analytics November 2, 2020
Researchers conducted genetic testing on cancer patients and saw that one in eight had an inherited gene mutation, a finding that could lead to precision medicine therapies.
Broad-based genetic testing could identify inherited genetic mutations and accelerate precision medicine therapies for patients with cancer, according to a study published in JAMA Oncology.
Hereditary factors play a key role in the development of many cancers, researchers at Mayo Clinic’s Center for Individualized Medicine noted. Identifying genetic predispositions for certain cancers can have significant implications for treatment decisions, interventions, cancer screenings, and genetic testing for patients and close relatives.
Selecting patients for genetic testing has traditionally been based on pathologic features of the cancer, age at diagnosis, family history of cancer, and...
Today's Sponsors
Today's Sponsor